PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026Stem Cells Translational Medicine2 citationsOpen Access

Cell therapy for stroke and spinal cord injury in clinical trials

View Full Paper
YFYing FanSWSi Tau WongEGE. S. M. Goh

Key Points

  • This review aims to evaluate clinical trials investigating cell therapies for stroke and spinal cord injury.
  • Reviewed trials on clinicaltrials.gov for cell therapies targeting stroke and spinal cord injury
  • Included 40 trials for stroke and 32 for spinal cord injuries, focusing on completed and active studies
  • Analyzed types of cells used, including neural, mesenchymal, and haemopoietic cells
  • Some trials showed encouraging improvements in outcome measures for both conditions
  • Many trials have been ongoing for up to 20 years, indicating the long timeline of research
  • Cell transplantation remains unestablished as a standard treatment requiring further validation

Abstract

Abstract Brain injury describes a variety of injuries to the tissues and blood vessels in the head. It can be external such as in road accident or physical assaults or internal such as a stroke. Regardless, they are largely incurable with a long route to recovery with symptoms-relieving medications and rehabilitation. As such, many therapies were explored including cell therapy. However, not all were evidence based and in many instances banking of patients’ desperation, many treatments were done without any evidence from clinical trials. Here, we reviewed clinical trials on clinicaltrials.gov for stroke and spinal cord injury where there are cellular therapies transplanting neural, mesenchymal, and haemopoietic cells. We present and discuss 40 trials involving cell therapies for stroke and 32 for spinal cord injuries that are either completed or active. Although some trials began as long as 20 years ago and have shown encouraging improvements in various scale scores for both stroke and spinal cord injury, cell transplantation for brain injuries remains an evolving field that requires further research before it can be established as a standard treatment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fan et al. (2025) studied this question.

synapsesocial.com/papers/698829520fc35cd7a8849932https://doi.org/10.1093/stcltm/szaf082
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical trial landscape of cell therapy for spinal cord injury: from integrated practices to future developments2026
  2. 2Restoring neuroplasticity after CNS trauma: cell therapy approaches in spinal cord and traumatic brain injury2026
  3. 3Cell Therapy for Spinal Cord Injury: Mechanistic Insights and Translational Challenges2026 · 1 citations
  4. 4THE CURRENT STATE OF STEM CELL THERAPY FOR SPINAL CORD INJURY AND OTHER SYSTEMIC INJURIES2024
  5. 5Regenerative Medicine Strategies for Spinal Cord Injury: Advances in Stem Cell Therapy2026 · 1 citations